To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Brain cancer; breast cancer; colorectal cancer
Patient sample and mouse studies suggest dual inhibition of miR-25 and miR-93 or
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury